29549424|t|Energy metabolism in ALS: an underappreciated opportunity?
29549424|a|Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive and fatal neurodegenerative disorder that primarily affects motor neurons. Despite our increased understanding of the genetic factors contributing to ALS, no effective treatment is available. A growing body of evidence shows disturbances in energy metabolism in ALS. Moreover, the remarkable vulnerability of motor neurons to ATP depletion has become increasingly clear. Here, we review metabolic alterations present in ALS patients and models, discuss the selective vulnerability of motor neurons to energetic stress, and provide an overview of tested and emerging metabolic approaches to treat ALS. We believe that a further understanding of the metabolic biology of ALS can lead to the identification of novel therapeutic targets.
29549424	21	24	ALS	Disease	MESH:D000690
29549424	59	88	Amyotrophic lateral sclerosis	Disease	MESH:D000690
29549424	90	93	ALS	Disease	MESH:D000690
29549424	135	161	neurodegenerative disorder	Disease	MESH:D019636
29549424	275	278	ALS	Disease	MESH:D000690
29549424	387	390	ALS	Disease	MESH:D000690
29549424	451	454	ATP	Chemical	MESH:D000255
29549424	545	548	ALS	Disease	MESH:D000690
29549424	549	557	patients	Species	9606
29549424	721	724	ALS	Disease	MESH:D000690
29549424	794	797	ALS	Disease	MESH:D000690
29549424	Negative_Correlation	MESH:D000255	MESH:D000690

